What is Merck & Co.'s EPS (basic)?

Merck & Co. (MRK) reported EPS (basic) of -$1.72 in Q1 2026.

How has Merck & Co.'s EPS (basic) changed year-over-year?

Merck & Co.'s EPS (basic) decreased by 185.6% year-over-year, from $2.01 to -$1.72.

What is the long-term trend for Merck & Co.'s EPS (basic)?

Over 3 years (2021 to 2025), Merck & Co.'s EPS (basic) has grown at a 12.2% compound annual growth rate (CAGR), from $5.17 to $7.30.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Merck & Co. MRK EPS (Basic)

EPS (Basic) at other companies

Bristol-Myers SquibbBMY

$1.31+8.3%

PfizerPFE

$0.47-9.6%

Johnson & JohnsonJNJ

$2.17-52.5%

Regeneron PharmaceuticalsREGN

$6.99-7.8%

CytokineticsCYTK

-$1.67-22.8%

Phibro Animal HealthPAHC

$0.59+13.5%

Other financials

Income statement

See full

Revenue$16.3B+4.9%

Gross profit$12.1B-0.2%

Net income-$4.2B-183%

EPS (diluted)-$1.72-186%

Balance sheet

See full

Cash & equivalents$5.4B-38.2%

Total debt$49.1B+35.8%

Total equity$45.9B-5.1%

Total assets$128.69B+11.8%

Cash flow

See full

Operating cash flow$3.9B+56.7%

CapEx$991.0M-25.4%

Free cash flow$2.9B+150%

Valuation

See full

Market cap$317.37B+60.3%

Enterprise value$361.07B+59.3%

P/E35.5×+23.5×

P/S4.8×+1.7×

Profitability

See full

Gross margin73.9%-2.5pp

Net margin13.6%-13.7pp

FCF margin21.5%-5.2pp

Returns & leverage

See full

Return on equity19%-20.3pp

Debt / equity1.1×+0.3×

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Merck & Co.'s EPS (basic)?: Merck & Co. (MRK) reported EPS (basic) of -$1.72 in Q1 2026.
How has Merck & Co.'s EPS (basic) changed year-over-year?: Merck & Co.'s EPS (basic) decreased by 185.6% year-over-year, from $2.01 to -$1.72.
What is the long-term trend for Merck & Co.'s EPS (basic)?: Over 3 years (2021 to 2025), Merck & Co.'s EPS (basic) has grown at a 12.2% compound annual growth rate (CAGR), from $5.17 to $7.30.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.